BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6322362)

  • 1. A direct comparison of oral treatments with BAY-n-7133, BAY-1-9139 and ketoconazole in experimental murine coccidioidomycosis.
    Levine HB
    Sabouraudia; 1984; 22(1):37-46. PubMed ID: 6322362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of BAY n 7133 and BAY 1 9139 in vitro and in experimental murine coccidioidomycosis.
    Hoeprich PD; Merry JM
    Eur J Clin Microbiol; 1985 Aug; 4(4):400-3. PubMed ID: 4043057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of the triazole Bay R 3783 in mouse models of coccidioidomycosis, blastomycosis, and histoplasmosis.
    Pappagianis D; Zimmer BL; Theodoropoulos G; Plempel M; Hector RF
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1132-8. PubMed ID: 2393272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azole antifungal drugs in treatment of coccidioidomycosis.
    Graybill JR
    Semin Respir Infect; 1986 Mar; 1(1):53-60. PubMed ID: 3317599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of the modified polyene N-D-ornithyl amphotericin methyl ester and the azoles ICI 153066, Bay n 7133, and Bay l 9139 compared with those of amphotericin B and ketoconazole in the therapy of experimental blastomycosis.
    Lefler E; Brummer E; Perlman AM; Stevens DA
    Antimicrob Agents Chemother; 1985 Mar; 27(3):363-6. PubMed ID: 3994350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of murine coccidioidal meningitis with fluconazole (UK 49,858).
    Graybill JR; Sun SH; Ahrens J
    J Med Vet Mycol; 1986 Apr; 24(2):113-9. PubMed ID: 3014105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New azole compounds: vibunazole (Bay n7133) and Bay L9139, compared with ketoconazole in the therapy of systemic candidosis and in pharmacokinetic studies, in mice.
    Lefler E; Stevens DA
    J Antimicrob Chemother; 1985 Jan; 15(1):69-75. PubMed ID: 3972759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral therapy for experimental coccidioidomycosis with R41 400 (ketoconazole), a new imidazole.
    Levine HB; Cobb JM
    Am Rev Respir Dis; 1978 Oct; 118(4):715-21. PubMed ID: 707893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of murine coccidioidal meningitis with SCH39304.
    Defaveri J; Sun SH; Graybill JR
    Antimicrob Agents Chemother; 1990 Apr; 34(4):663-4. PubMed ID: 2160794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimycotic activity of BAY N 7133 in animal experiments.
    Plempel M
    J Antimicrob Chemother; 1984 May; 13(5):447-63. PubMed ID: 6330018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New and prospective developments in antifungal drugs.
    Cauwenbergh G
    Acta Derm Venereol Suppl (Stockh); 1986; 121():147-53. PubMed ID: 3012922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis.
    Stevens DA; Stiller RL; Williams PL; Sugar AM
    Am J Med; 1983 Jan; 74(1B):58-63. PubMed ID: 6295153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketoconazole for treatment of disseminated coccidioidomycosis.
    Catanzaro A; Einstein H; Levine B; Ross JB; Schillaci R; Fierer J; Friedman PJ
    Ann Intern Med; 1982 Apr; 96(4):436-40. PubMed ID: 6279004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketoconazole: a major innovation for treatment of fungal disease.
    Graybill JR; Drutz DJ; Murphy AL
    Ann Intern Med; 1980 Dec; 93(6):921-3. PubMed ID: 6255850
    [No Abstract]   [Full Text] [Related]  

  • 15. Miconazole therapy for coccidioidomycosis.
    Hoeprich PD; Goldstein E
    JAMA; 1974 Nov; 230(8):1153-7. PubMed ID: 4479523
    [No Abstract]   [Full Text] [Related]  

  • 16. Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations.
    Tucker RM; Denning DW; Arathoon EG; Rinaldi MG; Stevens DA
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):593-601. PubMed ID: 2170479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ketoconazole, Bay N7133, and Bay L9139 in the treatment of experimental vaginal candidiasis.
    Sobel JD; Muller G
    Antimicrob Agents Chemother; 1983 Sep; 24(3):434-6. PubMed ID: 6314893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Imidazole preparations in mycology].
    Sheklakov ND; Rukavishnikova VM
    Vestn Dermatol Venerol; 1984 Jun; (6):51-8. PubMed ID: 6089467
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of experimental murine aspergillosis with BAY n7133.
    Graybill JR; Kaster SR; Drutz DJ
    J Infect Dis; 1983 Nov; 148(5):898-906. PubMed ID: 6313822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of the triazole D0870 in the treatment of experimental systemic coccidioidomycosis.
    Clemons KV; Stevens DA
    J Med Vet Mycol; 1994; 32(4):323-6. PubMed ID: 7983578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.